[Anti-inflammatory agents in current therapeutics].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D002062:Bursitis / Q000188:drug therapy; D003078:Colchicine / Q000627:therapeutic use; D003095:Collagen Diseases / Q000188:drug therapy; D003907:Dexamethasone / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology; D004347:Drug Interactions; D005439:Flufenamic Acid / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008528:Mefenamic Acid / Q000627:therapeutic use; D009544:Niflumic Acid / Q000627:therapeutic use; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D052256:Tendinopathy / Q000188:drug therapy; D014221:Triamcinolone / Q000009:adverse effects; D014717:Vertigo / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D014221:Triamcinolone; D008528:Mefenamic Acid; D009544:Niflumic Acid; D005439:Flufenamic Acid; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D010653:Phenylbutazone; D001241:Aspirin; D003078:Colchicine
Les anti-inflammatoires en thérapeutique courante